- Price
- $194.78
- Day
- -1.38%
- Mkt Cap
- $136.93B
- 52W Range
- $160.93 – $242.80
- Volume
- 4.91M
- Beta
- 0.82
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Rainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a senior advisor until March 31, 2027 to ensure a seamless transition.
Read full article
Argent Capital Management LLC trimmed its position in Danaher Corporation (NYSE: DHR) by 8.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 322,260 shares of the conglomerate's stock after selling 30,439 shares during the quarter. Danaher comprises 1.9% of Argent Capital
Read full article
For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return of 6.92% pure gross of fees (6.40% net of fees), underperforming the MSCI ACWI Index, which returned 14.93%, and the MSCI World Index, which returned 13.76%. During the quarter, we sold our positions in Danaher, Dolby Laboratories, and Tokyo Century and purchased Techtronic Industries and Wal-Mart de Mexico. Munich Re, the world's largest reinsurance company, was a detractor during the quarter.
Read full article
ADAR1 Capital Management LLC grew its holdings in shares of Danaher Corporation (NYSE: DHR) by 20.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 30,932 shares of the conglomerate's stock after acquiring an additional 5,332 shares during the quarter. ADAR1 Capital Management LLC's holdings in
Read full article
Caxton Associates LLP bought a new stake in Danaher Corporation (NYSE: DHR) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 5,612 shares of the conglomerate's stock, valued at approximately $1,064,000. Other institutional investors and hedge funds have also recently bought and sold
Read full article
Bank of Nova Scotia lessened its stake in shares of Danaher Corporation (NYSE: DHR) by 1.6% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 202,353 shares of the conglomerate's stock after selling 3,275 shares during the period. Bank of Nova Scotia's holdings in Danaher were
Read full article
The company delivered a mixed earnings report, but the sell-off looks like an overreaction.
Read full article
The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Danaher (DHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read full article
There's reason to believe the stock can stage a comeback after its worst day in two decades.
Read full article
Andra AP fonden raised its holdings in shares of Danaher Corporation (NYSE: DHR) by 648.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 76,642 shares of the conglomerate's stock after buying an additional 66,405 shares during the period. Andra AP fonden's holdings
Read full article
Stock futures are rising after three straight days of declines for major indexes; chip stocks are leading the rebound as volatility in the AI trade persists; several big-name companies reported earnings this morning ahead of Big Tech results tomorrow; Nebius shares are surging on news Nvidia as increased its stake in the Dutch AI infrastructure company; and SpaceX shares are rising after closing lower for the seventh consecutive sessions. Here's what you need to know today.
Read full article
DHR beats Q2 estimates as Life Sciences posts its strongest quarter in years, prompting the company to raise its 2026 adjusted EPS outlook.
Read full article